A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration

Neuron

Volumn 23, Issue 1, 1999, Pages 181-192

  Hodgson, J Graeme ^a   Agopyan, Nadia ^a   Gutekunst, Claire Anne ^b   Leavitt, Blair R ^a   Lepiane, Fred ^b   Singaraja, Roshni ^a   Smith, Desmond J ^c   Bissada, Nagat ^a   McCutcheon, Krista ^a   Nasir, Jamal ^a   Jamot, Laure ^d   Xiao Jiang, Li ^b   Stevens, Mary E ^c   Rosemond, Erica ^a   Roder, John C ^d   Phillips, Anthony G ^b   Rubin, Edward M ^c   Hersch, Steven M ^b   Hayden, Michael R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DNA FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; CYTOTOXICITY; ELECTROPHYSIOLOGY; FEMALE; HUNTINGTON CHOREA; MOTOR CONTROL; MOUSE; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSGENIC MOUSE;

EID: 0033136692     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80764-3     Document Type: Article

References (46)

1. Albin, R.L., and Greenamyre, J.T. (1992). Alternative excitotoxic hypothesis. Neurology 42, 733-738.
2. Beal, M.F., Lowall, N.W., Swartz, K.J., Ferrante, R.J., and Martin, J.B. (1989). Differential sparing of somatostain-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions. Synapse 3, 38-47.
3. Becher, M.W., Rubinsztein, D.C., Leggo, J., Wagster, M.V., Stine, O.C., Ranen, N.G., Franz, M.L., Abbott, M.H., Sherr, M., Macmillan, et al. (1997). Dentatorubral and pallidoluysian atrophy (DRPLA). Clinical and neuropathological findings in genetically confirmed North American and European pedigrees. Mov. Disord. 12, 519-530.
4. Buxbaum, J.D., Choi, E.K., Luo, Y., Lilliehook, C., Crowley, A.C., Merriam, D.E., and Wasco, W. (1998). Calsenilin: A calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nat. Med. 4, 1177-1181.
5. Chen, N., Luo, T., Wellington, C., Metzler, M., McCutcheon, K., Hayden, M.R., and Raymond, L.A. (1999). Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin. J. NeuroChem. 72, 1820-1898.
6. Cohen, J., and Wilkin, G.P. (1995). Neural Cell Culture (New York: Oxford University Press).
7. Cooper, J.K., Schilling, G., Peters, M.F., Herring, W.J., Sharp, A.H., Kaminsky, Z., Masone, J., Khan, F.A., Delanoy, M., Borchelt, D.R., et al. (1998). Truncated n-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum. Mol. Genet. 7, 783-790.
8. Coyle, J.T., and Puttfarchen, P. (1993). Oxidative stress, glutamate, and neurodegenerative diseases. Ann. Neurol. 38, 357-366.
9. Davies, S.W., Turmaine, M., Cozens, B.A., Difiglia, M., Sharp, A.H., Ross, C.A., Scherzinger, E., Wanker, E.E., Mangiarini, L., and Bates, G.P. (1997). Formation of neuronal intranuclear inclusions (NII) underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548.
10. Difiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.P., Carraway, R., Reeves, S.A., et al. (1995). Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14, 1075-1081.
11. Difiglia, M., Sapp, E., Chase, K.O., Davies, S.W., Bates, G.P., Vonsattel, J.P., and Aronin, N. (1997). Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993.
12. Dingledine, R. (1984). Brain Slices (New York: Plenum Press).
13. Duff, K., McGuigan, A., Huxley, C., Schulz, F., and Hardy, J. (1994). Insertion of a pathogenic mutation into a yeast artificial chromosome containing the human amyloid precursor protein gene. Gene Ther. 1, 70-75.
14. Duyao, M.P., Auerbach, A.B., Ryan, A., Persichetti, F., Barnes, G.T., McNeil, S.M., Ge, P., Vonsattel, J.-P., Gusella, J.F., Joyner, A.L., and Macdonald, M.E. (1995). Inactivation of the mouse huntington's disease gene homolog hdh. Science 269, 407-410.
15. Ferrante, R.J., Kowall, N.W., Beal, M.F., Richardson, E.P., Jr., Bird, E.D., and Martin, J.B. (1985). Selective sparing of a class of striatal neurons in huntington's disease. Science 230, 561-563.
16. Goldberg, Y.P., Nicholson, D.W., Rasper, D.M., Kalchman, M.A., Koide, H.B., Graham, R.K., Bromm, M., Kazemi-Esfarjani, P., Thornberry, N.A., Vaillancourt, J.P., and Hayden, M.R. (1996). Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat. Genet. 13, 442-449.
17. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
18. Gutekunst, C.-A., Levey, A.I., Heilman, C.J., Whaley, W.L., Yi, H., Nash, N.R., Rees, H.D., Madden, J.J., and Hersch, S.M. (1995). Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc. Natl. Acad. Sci. USA 92, 8710-8714.
19. Gutekunst, C.-A., Li, S.-H., Yi, H., Mulroy, J.S., Kuemmerle, S., Jones, R., Rye, D., Ferrante, R.J., Hersch, S.M., and Li, X.-J. (1999). Nuclear and neuropil aggregates in huntington's disease: Relationship to neuropathology. J. Neurosci. 19, 2522-2534.
20. Hackam, A.S., Singaraja, R., Wellington, C.L., Metzler, M., McCutcheon, K., Zhang, T., Kalchman, M., and Hayden, M.R. (1998). The influence of huntingtin protein size on nuclear localization and cellular toxicity. J. Cell Biol. 141, 1097-1105.
21. Hackam, A.S., Singaraja, R., Zhang, T., Can, L., and Hayden, M.R. (1999). In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in huntington disease. Hum. Mol. Genet. 8, 25-33.
22. Harper, P.S. (1991). Huntington's Disease (Philadelphia: W.B. Saunders).
23. Hayden, M.R. (1981). Huntington's Chorea (Berlin: Springer-verlag).
24. Hodgson, J.G., Smith, D.J., McCutcheon, K., Koide, H.B., Nishiyama, K., Dinulos, M.B., Stevens, M.E., Bissada, N., Nasir, J., Kanazawa, K., et al. (1996). Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype. Hum. Mol. Genet. 5, 1875-1885.
25. Huntington's Disease Collaborative Research Group (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on huntington's disease chromosomes. Cell 72, 971-983.
26. Kalchman, M.A., Koide, H.B., McCutcheon, K., Graham, R.K., Nichol, K., Nishiyama, K., Lynn, F.C., Kazemi-Esfarjani, P., Wellington, C.L., Metzler, M., et al. (1997). HIP1, a human homolog of S. Cerevisiae sla2p, interacts with membrane-associated huntingtin in the brain. Nat. Genet. 16, 44-53.
27. Kim, T.-W., and Tanzi, R.E. (1998). Neuronal intranuclear inclusions in polyglutamine diseases: Nuclear weapons or nuclear fallout? NeuRon 21, 657-659.
28. Klement, I.A., Skinner, P.J., Kaytor, M.D., Yi, H., Hersch, S.M., Clark, H.B., Zoghbi, H.Y., and Orr, H.T. (1998). Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95, 41-53.
29. Li, X.J., Li, S.H., Sharp, A.H., Nucifora, F.C., Jr., Schilling, G., Lanahan, A., Worley, P., Snyder, S.H., and Ross, C.A. (1995). A huntingtin- Associated protein enriched in brain with implications for pathology. Nature 378, 398-402.
30. Malenka, R.C., Kauer, J.A., Zucker, R.S., and Nicoll, R.A. (1988). Postsynaptic calcium is sufficient for potentiation of hippocampal synaptic transmission. Science 242, 81-84.
31. Malenka, R.C., Lancaster, B., and Zucker, R.S. (1992). Temporal limits on the rise in postsynpatic calcium required for the induction of long-term potentiation. Neuron 9, 121-128.
32. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S.W., and Bates, G.P. (1996). Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506.
33. Martindale, D., Hackam, A.S., Wieczorek, A., Ellerby, L., Wellington, C.L., McCutcheon, K., Singaraja, R., Kazemi-Esfarjani, P., Devon, R., Bredesen, D.E., Tufaro, F., and Hayden, M.R. (1998). Length of the protein and polyglutamine tract influence localization and frequency of intracellular aggregates of huntingtin. Nat. Genet. 18, 150-154.
34. Morris, R.G., Anderson, E., Lynch, G.S., and Baudry, M. (1986). Selective impairment of learning and blockade of long-term potentiation by an n-methyl-d-aspartate receptor antagonist, AP5. Nature 19, 774-776.
35. Nasir, J., Floresco, S.B., O'Kusky, J.R., Diewert, V.M., Richman, J.M., Zeisler, J., Borowski, A., Marth, J.D., Phillips, A.G., and Hayden, M.R. (1995). Targeted disruption of the huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81, 811-823.
36. Paulson, H.L., Perez, M.K., Trottier, Y., Trojanowski, J.Q., Subramony, S.H., Das, S.S., Vig, P., Mandel, J.-L., Fischbeck, K.H., and Pittman, R.N. (1997). Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19, 333-344.
37. Reddy, P.H., Williams, M., Charles, V., Garrett, L., Pike-Buchanan, L., Whetsell, W.O., Jr., Miller, G., and Tagle, D.A. (1998). Behavioral abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cdna. Nat. Genet. 20, 198-202.
38. Saudou, F., Finkbeiner, S., Devys, D., and Greenberg, M.E. (1998). Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55-66.
39. Schilling, G., Becher, M.W., Sharp, A.H., Jinnah, H.A., Duan, K., Kotzuk, J.A., Slunt, H.H., Ratovitski, T., Cooper, J.K., Jenkins, N.A., et al. (1999). Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant n-terminal fragment of huntingtin. Hum. Mol. Genet. 8, 397-407.
40. Skinner, P.J., Koshy, B.T., Cummings, C.J., Klement, I.A., Helin, K., Servadio, A., Zoghbi, H.Y., and Orr, H.T. (1997). Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 389, 971-974.
41. Spargo, E., Everall, I.P., and Lantos, P.L. (1993). Neuronal loss in the hippocampus in huntington's disease: A comparison with HIV infection. J. Neurol. Neurosurg. Psychiatry 56, 487-491.
42. Vonsattel, J.P., Myers, R.H., Stevens, T.J., Ferrante, R.J., Bird, E.D., and Richardson, E.P., Jr. (1985). Neuropathological classification of huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559-577.
43. Wanker, E.E., Rovira, C., Scherzinger, E., Hasenbank, R., Walter, S., Tait, D., Colicelli, J., and Lehrach, H. (1997). HIP1: A huntingtin interacting protein isolated by the yeast two-hybrid system. Hum. Mol. Genet. 6, 487-495.
44. Wellington, C.L., Ellerby, L.M., Hackam, A.S., Margolis, R.L., Trifiro, M.A., Singaraja, R., McCutcheon, K., Salvesen, G.S., Propp, S.S., Bromm, M., et al. (1998). Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem. 273, 9159-9167.
45. White, J.K., Auerbach, W., Duyao, M.D., Vonsattel, J.P., Gusella, J.F., Joyner, A.L., and Macdonald, M.E. (1997). Huntingtin is required for neurogenesis and is not impaired by the huntington's disease CAG expansion. Nat. Genet. 17, 404-410.
46. Zeitlin, S., Liu, J.-P., Chapman, D.L., Papaioannou, V.E., and Efstratiadis, A. (1995). Increased apoptosis and early embryonic lethality in mice nullizygous for the huntington's disease gene homologue. Nat. Genet. 11, 155-162.